Roche Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Make Smarter Decisions with the Full Value Chain Report
This Roche Value Chain Analysis helps you understand how Roche creates value across support and primary activities in a clear, structured format. The page already shows a real preview of the actual analysis, so you can review the content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
Roche's firm infrastructure links headquarters, finance, legal, compliance, and quality systems across Pharmaceuticals and Diagnostics, which helps steer capital and approvals in 100+ markets. Roche also runs 2 highly regulated divisions under one control layer, so risk checks and audit trails stay aligned. That matters because drug and diagnostic launches often take years, and delays in one market can hit global rollout and cash flow.
Human Resource Management
Roche depends on scientists, clinicians, regulatory specialists, engineers, and plant staff to keep its research-led model moving. With about 103,000 employees in 2025, Roche needs tight hiring, training, and retention to protect quality and speed up approvals. In this business, one small execution error can affect patient safety, regulatory clearance, and sales.
Technology Development
Roche keeps pouring money into technology development across drug discovery, biologics, companion diagnostics, tissue diagnostics, and digital tools. This links medicines with tests, so Roche can target patients better, sharpen trial design, and support precision medicine. The integrated R&D model also helps Roche build differentiated products and recurring diagnostic revenue.
Procurement
Roche sources APIs, biologic inputs, reagents, device parts, packaging, and specialist manufacturing services from a wide global supplier base. This matters because regulated inputs must meet tight rules on purity, traceability, and steady supply, especially across Roche's pharma and diagnostics lines. Roche's scale helps it spread sourcing risk, lock in quality controls, and manage costs across a complex network. Strong procurement also supports continuity when single-source items or cold-chain inputs face disruption.
Roche's 103,000-Person Backbone Powers Global Science and Compliance
Roche's support activities are built to protect a science-led model: firm infrastructure links finance, legal, compliance, and quality controls across Pharmaceuticals and Diagnostics in 100+ markets. In 2025, Roche had about 103,000 employees, so hiring, training, and retention are core to speed and regulatory quality. Procurement and technology development also keep supply, traceability, and precision medicine on track.
| 2025 metric | Value |
|---|---|
| Employees | About 103,000 |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
Roche's inbound logistics moves biological materials, chemicals, lab reagents, instrument parts, and packaging into two divisions: Pharmaceuticals and Diagnostics. Cold-chain handling, supplier qualification, and incoming quality checks protect temperature-sensitive inputs before production, which lowers batch-failure risk and keeps manufacturing and test supply reliable.
Operations
Roche runs regulated global sites that make biologics, small molecules, diagnostic instruments, test kits, and tissue-based assays. Operations matter because higher yield, strict compliance, and tight batch consistency protect launch readiness and gross margin. Roche also links manufacturing to R&D, which helps scale complex therapies and supports recurring diagnostic consumables.
Outbound Logistics
Roche moves prescription medicines, diagnostics, and reagents through hospitals, labs, pharmacies, distributors, and direct channels in more than 100 countries. For biologics and testing products, cold-chain control, traceability, and local release rules help protect quality and keep shipments compliant. Faster, tighter distribution cuts stock-outs and service delays, which matters when patients and labs depend on on-time supply.
Marketing and Sales
Roche sells to oncologists, specialists, hospitals, laboratories, payers, and health systems through field teams, medical affairs, and account-based selling. In 2024, Roche reported group sales of CHF 60.5 billion, with Pharmaceuticals at CHF 46.2 billion and Diagnostics at CHF 14.3 billion, showing how its sales model supports both launch-led drug demand and recurring test use.
In pharma, clinical evidence and reimbursement drive uptake, so Roche pairs data-heavy promotion with payer access work. In diagnostics, winning instrument placements helps lock in reagent pull-through, which can turn one sale into a longer usage stream.
Service
Roche service covers instrument maintenance, software updates, training, assay troubleshooting, safety monitoring, and medical information support. In diagnostics, this keeps analyzers running and helps protect test quality; in medicines, it supports pharmacovigilance and post-market surveillance. Strong service lifts customer loyalty, cuts downtime, and extends the recurring value of Roche installed systems.
Roche's 2024 sales hit CHF 60.5 billion, led by Pharma
Roche's primary activities turn regulated inputs into drugs, diagnostics, and consumables, then move them through cold-chain and direct health-system channels. In 2024, Roche posted CHF 60.5 billion group sales: Pharmaceuticals CHF 46.2 billion and Diagnostics CHF 14.3 billion.
| 2024 | CHF bn |
|---|---|
| Group sales | 60.5 |
| Pharma | 46.2 |
| Diagnostics | 14.3 |
Preview the Actual Deliverable
Roche Reference Sources
This is the actual Roche Value Chain Analysis document you'll receive after purchase – no sample, no placeholders, just the real file. The preview below is taken directly from the full report, so what you see is exactly what you get. Buy now to unlock the complete, detailed version.
Frequently Asked Questions
Roche's strongest support is the combination of global infrastructure, deep scientific talent, and heavy R&D investment. Roche operates through 2 major divisions, serves 100+ countries, and employs roughly 100,000 people. That scale helps Roche coordinate approvals, quality, and capital allocation across medicines and diagnostics globally.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.